VII. Zervixkarzinom

1. Bader A., Winter R., Haas J., Tamussino K.: Where to look for the sentinel lymph node in cervical cancer. Am J Obstet Gynecol 2007; 197:678.e1-678.e7
2. Balleyguer C., Sala E., Cunha Da T., Bergman A., Brkljacic B., Danza F., Forstner R., Hamm B., Kubik-Huch R., Lopez C., Manfredi R., McHugo J., Oleaga L., Togashi K., Kinkel K.: Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology (2011). Eur Radiol 21:1102-1110
3. Benedet J., Anderson G.: Stage IA carcinoma of the cervix revisited. Obstet Gynecol 1996; 87:1052-1059
4. Benedetti-Panici P., Greggi S., Colombo A. et al.: Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: Results from the Italian multicenter randomized study. J Clin Oncol 2001; 20:179-188
5. Burghardt E., Baltzer J., Tulusan H., Haas J.: Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992; 70:648-655
6. Burghardt E.: Kolposkopie, spezielle Zervixpathologie. 1984; Thieme, Stuttgart
7. Chou H., Chang T., Yen T. et al.: Low value of 18-F-fluoro-2-deoxy-D-glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 2006; 24:123-128 8. Eifel P., Winter K., Morris M. et al.: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of Radiation Therapy Oncology Group Trial (RTOG) 90–01. J Clin Oncol 2004; 22:872-880
9. Friedberg V., Herzog R.: Die Therapie des Zervixkarzinoms. In: Friedberg V., Thomsen K. (Hrsg.). Gynäkologie und Geburtshilfe. Spezielle Gynäkologie 2; S 134-161. 1988; Thieme, Stuttgart
10. FUTURE II study Group: Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials. Lancet 2007; 369:1861-1868
11. Fyles A.W., Milosevic M., Pintilie M. et al.: Anemia, hypoxia and transfusion in patients with cervix cancer: a review. Radiother Oncol 2000; 57:13-19
12. Girardi F., Pickel H., Winter R.: Pelvic and parametrial lymph nodes in the quality control of the surgical treatment of cervical cancer. Gynecol Oncol 1993; 50:330-333
13. Hacker N., Wain G., Nicklin J.: Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int J Gynecol Cancer 1995; 5:250-256
14. Joura E., Leodolter S., Hernandez-Avila M. et al.: Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) virus-like-particle vaccine against high-grade vulval and vaginal lesions: a combined analysis of three
randomised clinical trials. Lancet 2007; 369:1693-1702
15. Kapp K.S., Poschauko J., Geyer E. et al.: Evaluation of the effect of routine packed red blood cell transfusion in anemic cervix cancer patients treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 2002; 54:58-66
16. Kapp K.S., Stuecklschweiger G.F., Kapp D.S. et al.: Carcinoma of the cervix; analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 1997; 42:143-153
17. Kaufmann M., Costa S.D., Scharl A. (Hrsg.): Die Gynäkologie. 2003, Springer, Berlin, Heidelberg, New York
18. Lagasse L. D., Creasman W. T., Shingelton H. M., Ford J. H., Blessing J.A.: Results and complications of operative staging in cervical cancer; experience of the GOG Goup. Gynecol Oncol 1980; 46:507-510
19. Landoni F., Maneo A., Colombo A. et al.: Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 1997; 350:535-540
20. Leblanc E., Gauthier H., Querleu D., Ferron G., Zerdoud S., Morice P., Uzan C., Lumbroso S., Lecuru F., Bats A. S., Ghazzar N., Bannier M., Houvenaeghel G., Brenot-Rossi I., Narducci F.: Accuracy of 18 Fluroro-2deoxy-D-glucose Positron Emission Tomography in the Pretherapeutic Detection of Occult Para-aortic Node Involvement in Patients with a Locally Advanced Cervical Carcinoma (2011). Ann Surg Oncol 18:2302-2309
21. Lee J., Lee K., Nam J. et al.: Prognostic factors in FIGO stage IB–IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: Results of a multi-center retrospective Korean study. Ann Oncol 2007; 19:321-326
22. Mayrand M., Duarte-Franco E., Rodrigues I. et al.: Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357:1579-1588
23. Paavonen J., Jenkins D., Bosch F.X. et al.: Efficacy of a prophylactic adjuvant bivalent L1 virus-like vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomized controlled trial. Lancet 2007; 369:2161-2170
24. Peters W.A., Liu P., Barrett R. et al.: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18:1606-1613
25. Petru E., Tamussino K., Lahousen M. et al.: Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer. Am J Obstet Gynecol 1989; 161:937-941
26. Petru E., Pasterk C., Reich O. et al.: Small cell carcinoma of the uterus and vagina. Experience with ten patients. Arch Gynecol Obstet 2005; 271:316-319
27. Podczaski E., Palombo C., Manetta A. et al.: Assessment of pretreatment laparotomy in patients with cervical carcinoma prior to radiotherapy. Gynecol Oncol 1989; 33:71-75
28. Reich O., Lahousen M., Pickel H. et al.: Cervical intraepithelial neoplasia III: Long-term follow-up after cold-knife coization with involved margins. Obstet Gynecol 2002; 99:193-196
29. Rose P., Bundy B., Watkins E. et al.: Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999; 340:1144-1153
30. Rotman M., Sedlis A., Piedmonte M. et al.: A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: Follow-up of a Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 2006; 65:169-176
31. Sardi J., Sananes C., Giaroli A. et al.: Results of a prospective randomized trial with neoadjuvant chemotherapy in stage IB, bulky, squamous carcinoma of the cervix. Gynecol Oncol 1993; 49:156-165
32. Sawaya G., McConnell J., Kulasingam S. et al.: Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003; 349:1501-1509
33. Shankar S., Herschtal A., Thomas J. M., Bernshaw D. M., Gill S., Hicks R. J., Narayan K.: Impact of Post-Therapy Positron Emission Tomography on Prognostic Stratification and Surveillance After Chemoradiotherapy for Cervical Cancer (2011). Cancer 117:3981-3988
34. Shingleton H., Soong S., Gelder M. et al.: Clinical and histopathological factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989; 73:1027-1034
35. Small W., Winter K., Levenback C. et al.: Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive paraaortic or high common iliac lymph nodes: Results of arm 1 of RTOG 0116. Int J Radiat Oncol Biol Phys 2007; 68:1081-1087
36. Stehman F.B., Bundy B.N., DiSaia P.J. et al.: Carcinoma of the cervix treated with radiation therapy I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991; 67:2776-2785
37. Sutton G., Bundy B., Delgado G. et al.: Ovarian metastases in stage Ib carcinoma of the cervix: A Gynecologic Oncology Group Study. Am J Obstet Gynecol 1992; 166:50-53
38. Vange V., Weverling G., Ketting B. et al.: The prognosis of cervical cancer associated with pregnancy: A matched cohort study. Obstet Gynecol 1995; 85:1022-1026
39. Webb M., Symmonds R.: Site of recurrence of cervical cancer after radical hysterectomy. Am J Obstet Gynecol 1980; 138:813-817
40. Winter R., Petru E., Haas J.: Pelvic and para-aortic lymphadenectomy in cervical cancer. Bailliere’s Clin Obstet Gynaecol 1988; 2:857-866